Unregistered Sales of Equity Securities and Use Of Proceeds
−Removed: were no unregistered sales of the Company’s equity securities during the three months ended September 30, 2022 that were not previously
+Added: were no unregistered sales of the Company’s equity securities during the three months ended December 31, 2022 that were not previously
reported in an Annual Report on Form 10-K, a Quarterly Report on Form 10-Q, or a Current Report on Form 8-K except as follows:
−Removed: the three months ended September 30, 2022, 600 shares of Series E Preferred Stock were converted into 9,920,887 shares of common stock .
−Removed: All of the shares issued pursuant to the final Order in connection with the litigation discussed in Part II, Item 1 of this report have
−Removed: been issued in reliance on the exemption under Section 3(a)(10) of the Securities Act.
−Removed: August 1, 2022, the Company issued 250,000 shares of common stock to a consultant per the terms of an agreement from June 2021, to be
−Removed: issued upon the approval of a patent.
+Added: the three months ended December 31, 2022, the Company sold 17,175,675 shares of common stock at a net amount of approximately $1,378,000,
+Added: at share prices ranging from $0.08 to $0.10.
otherwise specified, the above securities were issued in reliance on the exemption under Section 4(a)(2) of the Securities Act.
13 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.